ArticleHarm reduction journal2010
Drug use and opioid substitution treatment for prisoners.
Article in Harm reduction journal, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed.
- A randomized clinical trial of buprenorphine for prisoners: Findings at 12-months post-release.Drug and alcohol dependence · 2017Trial
- Extended-release naltrexone for pre-release prisoners: A randomized trial of medical mobile treatment.Contemporary clinical trials · 2017Trial
- A randomized controlled trial of prison-initiated buprenorphine: prison outcomes and community treatment entry.Drug and alcohol dependence · 2014Trial
- To better understand why people use new psychoactive substances in prison - outcomes of polish, qualitative study.Health & justice · 2026Article
- Long-Acting Buprenorphine Formulations as a New Strategy for the Treatment of Opioid Use Disorder.Journal of clinical medicine · 2023Article
- The relationship between police contacts for drug use-related crime and future arrests, incarceration, and overdoses: a retrospective observational study highlighting the need to break the vicious cycle.Harm reduction journal · 2022Observational
- Review
- Implementation of opioid maintenance treatment in prisons in North Rhine-Westphalia, Germany - a top down approach.Substance abuse treatment, prevention, and policy · 2020Article
- OUD Care Service Improvement with Prolonged-release Buprenorphine in Prisons: Cost Estimation Analysis.ClinicoEconomics and outcomes research : CEOR · 2020Article
- Prevalence of Opioid Dependence and Opioid Agonist Treatment in the Berlin Custodial Setting: A Cross-Sectional Study.Frontiers in psychiatry · 2020Article
- The Accessibility of Opioid Agonist Treatment and Its Forced Discontinuation in Swiss Prisons-Attitudes, Perceptions and Experiences of Defense Lawyers in Dealing With Detained Persons Using Opioids.Frontiers in psychiatry · 2020Article
- Optimising opioid substitution therapy in the prison environment.International journal of prisoner health · 2019Article
- Utilization of opioid agonist therapy among incarcerated persons with opioid use disorder in Vancouver, Canada.Drug and alcohol dependence · 2018Article
- HIV, Hepatitis C, TB, Harm Reduction, and Persons Deprived of Liberty: What Standards Does International Human Rights Law Establish?Health and human rights · 2016Article
- Trials and tribulations of conducting bio-behavioral surveys in prisons: implementation science and lessons from Ukraine.International journal of prisoner health · 2016Article
- Pattern of Substance Use and Related Factors in Male Prisoners.Addiction & health · 2016Article
- Pharmacotherapy for opioid dependence in jails and prisons: research review update and future directions.Substance abuse and rehabilitation · 2016Review
- Gender differences in recovery consequences among heroin dependent patients after compulsory treatment programs.Scientific reports · 2015Article
- Insufficient access to harm reduction measures in prisons in 5 countries (PRIDE Europe): a shared European public health concern.BMC public health · 2015Article
- Rapid Assessment Response (RAR) study: drug use, health and systemic risks--Emthonjeni Correctional Centre, Pretoria, South Africa.Harm reduction journal · 2014Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Drug use is prevalent throughout prison populations, and, despite advances in drug treatment programmes for inmates, access to and the quality of these programmes remain substantially poorer than those available for non-incarcerated drug users. Because prisoners may be at greater risk for some of the harms associated with drug use, they deserve therapeutic modalities and attitudes that are at least equal to those available for drug users outside prison. This article discusses drug use by inmates and its associated harms. In addition, this article provides a survey of studies conducted in prisons of opioid substitution therapy (OST), a clinically effective and cost-effective drug treatment strategy. The findings from this overview indicate why treatment efforts for drug users in prison are often poorer than those available for drug users in the non-prison community and demonstrate how the implementation of OST programmes benefits not only prisoners but also prison staff and the community at large. Finally, the article outlines strategies that have been found effective for implementing OST in prisons and offers suggestions for applying these strategies more broadly.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.